381O First-in-human/phase I trial of HS-20089, a B7-H4 ADC, in patients with advanced solid tumors

Jing Wu; J. Zhang; Han Li; Xiangyu Wang; Q.Y. Zhang; Yongyong Shi; Minhao Yan; Yueyin Pan; Aiguo Shen; Qian Chen; Qing Rao; Haidong Wei; Chong Li; Lijun Yang; Qianqian Huang; Zhijun Cao; Qiong Wu

doi:10.1016/j.annonc.2023.09.558

381O First-in-human/phase I trial of HS-20089, a B7-H4 ADC, in patients with advanced solid tumors

Jing Wu(Fudan University Shanghai Cancer Center), J. Zhang(Fudan University Shanghai Cancer Center), Han Li(Peking University), Xiangyu Wang(Zhejiang Cancer Hospital), Q.Y. Zhang(Harbin Medical University), Yongyong Shi(Tianjin Medical University Cancer Institute and Hospital), Minhao Yan(Zhengzhou University), Yueyin Pan(Anhui Provincial Hospital), Aiguo Shen(Anhui Provincial Hospital), Qian Chen(Sun Yat-sen University), Qing Rao(Sun Yat-sen University), Haidong Wei(Hansoh Pharma (China)), Chong Li(Hansoh Pharma (China)), Lijun Yang(Hansoh Pharma (China)), Qianqian Huang(Hansoh Pharma (China)), Zhijun Cao(Hansoh Pharma (China)), Qiong Wu(Hansoh Pharma (China))

Annals of Oncology

October 1, 2023

10.1016/j.annonc.2023.09.558

Cited by 17Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis